![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgeFr1PXXgzHiOwANoC-oy0OzDvMPdgsLSPXOaJn1P4xTr8wkucjTDFlHk4Q3w6iW7L6uXQK2vnLkz6ku8z1r0KO7O3yADmVvLY9VN7rCHi3cNWAaALfjWeoYyMPlW9DrVeVkRcv6E03y4W/s200/Citario.jpg)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhLjLOU3bzq5S4DBqJ9_t8SVDxua_5xO0IV-4SbxIkF-vT58-I3Btzh-j-Wq6nlTu6uKhspotZZXjbtRyYn8SjCR72gPdrWHX2A6MAQJiWGWLrwUmNCZrgwqxor26FKE2wrTkH_8XO4rexv/s200/Imagen4.jpg)
"The conventional thinking was that a linear increase of the sales force will generate a linear increase of revenue. I don't believe in this model,"
Michel Vounatsos,
Head of Merck's China Operations
Ver
Ver también:
PHARMA - Interviews - Vounatsos Michel
Hasta ahora...estabamos convencidos que:
Imagen: Curso Postgrado Mercadeo Farmacéutico/ Facultad de Farmacia/Universidad Central de Venezuela (UCV)
No hay comentarios:
Publicar un comentario